APA (7th ed.) Citation

Yang, H., Yang, H., Yu, S., Yu, S., Ge, H., & Ge, H. Leveraging immune checkpoint inhibitors in lung cancer patients with pre-existing autoimmune disease: Clinical insights, optimal timing, and predictive biomarkers for optimal treatment outcomes. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Yang, Hui, Hui Yang, Sheng Yu, Sheng Yu, Hong Ge, and Hong Ge. Leveraging Immune Checkpoint Inhibitors in Lung Cancer Patients with Pre-existing Autoimmune Disease: Clinical Insights, Optimal Timing, and Predictive Biomarkers for Optimal Treatment Outcomes. Frontiers Media S.A.

MLA (9th ed.) Citation

Yang, Hui, et al. Leveraging Immune Checkpoint Inhibitors in Lung Cancer Patients with Pre-existing Autoimmune Disease: Clinical Insights, Optimal Timing, and Predictive Biomarkers for Optimal Treatment Outcomes. Frontiers Media S.A.